Dementia treatment with stem cells; It is one of the most advanced applications of regenerative medicine, aiming to stop neuron loss in the brain, repair damaged nerve cells and support cognitive functions.
This method aims to slow down the rate of disease progression by suppressing chronic inflammation in the brain and protecting healthy tissues.
According to Assoc. Prof. Dr. Erdinç Özek, stem cells’ secretion of neurotrophic factors can make a significant difference in the patient’s daily quality of life by activating the brain’s own repair mechanisms.
What is Dementia and What Are Its Symptoms?
Dementia is not a single disease; It is the general name of a series of symptoms that affect memory, thinking, navigation and social abilities, making it difficult for a person to continue their daily life.
This condition, which occurs as a result of damage or death of nerve cells in the brain, is not just a natural result of aging, but a medical process.
The most common symptoms of dementia include:
Forgetting recent events or names (short-term memory loss).
Deterioration in the perception of time and space (disorientation).
Difficulty finding words and decreased communication skills.
Weakening of decision-making ability and personality changes.
Differences Between Dementia and Alzheimer’s
Although dementia and Alzheimer’s are often used interchangeably, there is a categorical difference between them.
Dementia is an “umbrella term”; Alzheimer’s is the most common type of dementia under this umbrella.
The table below compares the key differences between these two concepts and the focal points of stem cell therapy:
| Feature | Dementia | Alzheimer’s |
| Scope | It is a general group of symptoms. | It is a specific brain disease. |
| Cause | Stroke, vascular occlusion, Parkinson’s, etc. | Amyloid plaques and Tau protein accumulation. |
| Stem Cell Focus | General neuroprotection and cell repair. | Preventing plaque buildup and neuron repair. |
Stages of the Disease and Cell Loss in the Brain
Dementia is a progressive process that begins with the loss of communication between neurons in the brain.
Cell loss first begins in memory centers and spreads over time to include motor functions, language skills and reasoning areas of the brain.
The typical course of the disease is as follows:
Early Stage: Mild forgetfulness, tendency to social isolation.
Middle Stage: Need for help with daily tasks, sleep disorders, inability to recognize relatives.
Advanced Stage: Loss of physical functions (swallowing, walking), becoming completely dependent.
According to Assoc. Prof. Dr. Erdinç Özek, the earlier stem cell therapy is started, the higher the chance of preserving the “healthy cell reserve” in the brain; because saving a damaged cell rather than bringing back a dead cell gives clinically more successful results.
Clinical Experience Note (Anonymous Case):
A 68-year-old male patient with early-stage vascular dementia underwent a stem cell protocol to reduce neuroinflammation. In tests performed 4 months after treatment, an increase in the patient’s cognitive focus time and stabilization of the capacity to carry out daily activities (shopping on their own, reading newspapers) were observed.
How Does Stem Cell Therapy Work on Dementia?
Stem cells are “smart” biological agents used to slow down the biological processes that cause dementia progression at the molecular level and to trigger the brain’s self-repair mechanisms.
While traditional medicines only try to manage symptoms (signs), stem cell therapy aims to restore communication between neurons by targeting cellular destruction at the root of damage.
According to Assoc. Prof. Dr. Erdinç Özek, the greatest power of stem cells is that they migrate to damaged areas of the brain (homing ability), clear the toxic environment in that area and create a protective shield for healthy nerve tissue.
Neuroprotective Effect and Protection of Brain Cells
Neuroprotection means preventing the death of existing healthy brain cells and is the most critical stage of dementia treatment.
Stem cells close cell death pathways in the brain and increase the endurance of neurons thanks to the neurotrophic factors (such as BDNF and NGF) they secrete.
This protective effect slows down the rate of spread of the disease, allowing the patient to maintain their mental faculties for a longer period of time.
Reducing Neuro-inflammation
In all types of dementia, there is a chronic “inflammation”, that is, neuro-inflammation in the brain; This causes nerve cells to damage each other.
Mesenchymal stem cells extinguish this inflammation in the brain with their immune system regulatory (immunomodulatory) roles.
Microglial Regulation: They enable the brain’s defense cells (microglia) to switch to reparative mode, not aggressive mode.
Toxic Cleansing: They stabilize the inflammatory environment that predisposes to plaque formation in cases like Alzheimer’s.
Strengthening Synaptic Connections and New Cell Formation
The main cause of forgetfulness in dementia patients is the rupture of “synapses”, which are the communication points between neurons.
Stem cells rebuild these broken communication bridges by increasing the brain’s ability to make new connections, which we call “neuroplasticity”.
Synaptogenesis: Creates new connection pathways between existing nerve cells.
Cellular Regeneration: Although limited, it can trigger a partial cell renewal (neurogenesis) by stimulating stem cell reserves within the brain.
According to Assoc. Prof. Dr. Erdinç Özek; “Our main goal in dementia treatment is to preserve the working capacity of the brain as a whole, not just one region. When we strengthen synaptic connections thanks to stem cells, we can create a scientifically based improvement basis on the patient’s word finding speed or recall of recent events.”
The table below summarizes the main biological effects of stem cells on dementia and the response of these effects in the patient:
| Cellular Mechanism of Action | Equivalent in the Brain | Clinical Outcome in the Patient |
| Anti-Inflammation | Extinguishing neuronal fire | Reduced mental fatigue and confusion |
| Neurotrophic Support | Protecting healthy cells | Prolongation of the stage transition period of the disease |
| Synaptic Repair | Opening communication routes | Strengthening the ability to remember and focus |
Stem Cell Application Methods Used in Dementia Treatment
In diseases that directly affect the central nervous system, such as dementia and Alzheimer’s, the delivery of stem cells to the brain is the most critical stage.
Since the “blood-brain barrier”, which is a natural protection mechanism of the body, restricts the passage of externally administered substances to the brain, specialist physicians prefer different transfer methods according to the patient’s condition.
According to Assoc. Prof. Dr. Erdinç Özek, the success of the treatment is directly related to how densely the cells cross this barrier and reach the areas where damaged neurons are located (such as the hippocampus).
Intravenous (Intravenous Access) Administration
The intravenous method is the administration of stem cells into the systemic circulation through a vein.
Cells head to brain tissue by following inflammation signals (homing) in the body.
Advantage: It is very comfortable and reduces general inflammation in the brain by providing systemic immune regulation.
Effect: It increases nutrition by supporting the microvascular (capillary) structure throughout the brain.
Intrathecal (Cerebrospinal Fluid) Application
Intrathecal administration is the injection of cells from the lumbar region (via lumbar puncture) directly into the cerebrospinal fluid (CSF).
This method allows cells to reach the central nervous system directly, completely bypassing the blood-brain barrier.
According to Assoc. Prof. Dr. Erdinç Özek, in cases where cognitive losses are pronounced, the intrathecal route is the most effective option for cells to reach the target tissue in the shortest way and at the highest concentration.
Treatment Process and Clinical Procedures
The treatment process for dementia patients requires meticulous preparation.
Neurological Evaluation: The patient’s cognitive level (MMSE scores, etc.) and brain imaging results are analyzed.
Cell Preparation: In GMP-standard laboratories, mesenchymal stem cells are prepared in personalized doses.
Application: Under clinical conditions, the transfer is performed from the planned route under the supervision of a physician.
The following table compares the two main routes of administration used in the treatment of dementia:
| Route of administration | Target Region | Key Advantage |
| Intravenous (IV) | Systemic Circulation | Easy application, low invasive risk, systemic repair. |
| Intrathecal (IT) | Direct MSS | Crossing the blood-brain barrier, high access to neuronal regions. |
Which Stem Cells Are Used in the Treatment of Dementia?
The type of cell used in the treatment determines how long that cell will remain alive in the brain tissue and how much reparative factor it will secrete.
Today, the most successful results are obtained from mesenchymal stem cells, which have high regenerative capacity.
Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are defined as “smart cells”; because when they reach the damaged area, they have the ability to differentiate or send signals according to the need there.
Rather than directly renewing neurons in the brain, these cells secrete protective proteins that prevent existing cells from dying through what we call the “paracrine effect”.
Umbilical Cord and Bone Marrow-Derived Cells
Cells are obtained from two main sources:
Umbilical Cord (Mesenchymal): They are the youngest and fastest multiplying cells biologically. It has a very high compatibility with the immune system and is preferred primarily in neurological cases.
Bone Marrow (Autologous): It is obtained from the patient’s own body; Although their capacity decreases with age, it is safe in terms of being one’s own biological material.
According to Assoc. Prof. Dr. Erdinç Özek; “Rather than a uniform approach in dementia patients, combining the high dynamism of cord blood-derived cells with the intrathecal route of administration maximizes neuronal repair signals in the brain.”
Expected Outcomes and Success Rates of Stem Cell Therapy
Success in progressive diseases such as dementia and Alzheimer’s is not the complete eradication of the disease, but the pause of mental decline and the recovery of some of the lost functions.
Clinical studies show that the biochemical balance of the brain improves and synaptic density increases after stem cell transplantation.
According to Assoc. Prof. Dr. Erdinç Özek, the success of the treatment varies depending on factors such as the patient’s age, the stage of dementia and the accompanying arteriosclerosis, but significant stabilization is achieved in the early and middle stages.
Effects on Cognitive Functions and Memory
The main goal of treatment is to protect the hippocampus region, which holds short-term memory records.
Thanks to the factors secreted by stem cells, data transmission between neurons accelerates and the patient begins to move away from the state of “mental fog”.
Ability to Remember: Increased capacity to remember names, places, and recent events.
Focus and Attention: Recovery of scattered thoughts and prolongation of the time to concentrate on a task.
Wayfinding: Decrease in disorientation (getting lost, mixing space).
Contribution to Quality of Life and Changes in Daily Activities
Dementia affects not only memory, but also the patient’s self-care skills. Improvement at the cellular level directly affects the patient’s participation in social life.
Social Interaction: Strengthening communication with the environment and reducing blockages in vocabulary.
Psychological State: Regression in dementia-related agitation, depression and sleep disorders with reduced inflammation in the brain.
Self-Care: Prolongation of independence in basic needs such as eating and dressing on one’s own.
Post-Treatment Follow-up and Follow-up of the Process
Stem cell application is a start; The actual healing process becomes evident within the first 3 to 6 months after the application.
First 1 Month: With the decrease in inflammation in the brain, improvement in sleep patterns and mood begins.
3rd Month: Score increase or maintenance of the current score (stabilization) is observed in cognitive tests (MMSE).
6. Month and Beyond: It is the period when maximum clinical benefit is seen and maintenance doses are planned.
The following table summarizes the expected recovery periods after treatment in dementia patients:
| Recovery Period | Expected Clinical Development | Required Supportive Practices |
| 0 – 2 Months | Improvement in sleep quality, reduction of agitation | Cognitive exercises and balanced diet |
| 3 – 9 Months | Increased memory performance, remembering names | Social interaction and walking programs |
| 12. Month and Beyond | Maintaining functional independence | Periodic neurological control and follow-up dose |
Frequently Asked Questions
Does stem cell therapy completely end Alzheimer’s?
In today’s medical technology, there is no definitive “cure” treatment for Alzheimer’s; However, stem cells can significantly slow the progression of the disease, delaying the patient’s addiction for years.
How many times should the treatment be repeated?
Booster doses, which are usually given every 6-12 months depending on the stage of the disease, help to make the cognitive gains achieved permanent.
Are there any side effects?
Since the applied cells are mesenchymal, there is no risk of immune rejection. Mild headache or fatigue may occur after the application, these symptoms disappear within 24 hours.
What stage of patients is it suitable for?
Although it can be applied at any stage, the highest success rates are seen in “Early” and “Middle” stage dementia patients.
According to Assoc. Prof. Dr. Erdinç Özek; “Success in the treatment of dementia is when the patient is less restless in the evening, gets to know his family and can eat his own food. Stem cell therapy slows down the biological clock in the brain, giving the patient and his family a quality time period.”
Clinical Experience Note (Anonymous Case):
A 72-year-old female patient with the onset of Alzheimer’s underwent an intrathecal umbilical cord-derived stem cell session. It was reported that the patient, who asked the same questions 5 minutes apart before the application and confused the names of his grandchildren, diluted his questions and his word finding speed increased by 40% at the follow-up 4 months later.
Resource and Expert Knowledge
This article has been prepared with reference to Assoc. Prof. Dr. Erdinç Özek’s neurological rehabilitation and regenerative medicine protocols. Assoc. Prof. Dr. Erdinç Özek is a medical authority with deep clinical experience in personalized stem cell dosing and administration techniques in dementia cases in Turkey.
